Presenter: Dr. Michael Allan James McCormack BSc (Pharm) Pharm D
In episode 480, James and Mike talk about two recent meta-analyses that have done a solid job of looking at the impact of lowering blood pressure and using SGLT-2s and GLP-1s to reduce risk. Both publications lend credence to the concept of focusing much more on risk reduction goals than blood pressure or glucose thresholds….
This content is for *CFPC Member Rate, CFPC Member Rate, Non-CFPC Member Rate, and Resident members only.
Login Join Now
Login Join Now
Latest Podcasts
BS Medicine Episode #555: An ASA a day when a baby’s on the way?
In episode 555, James and Mike invite Jamie Falk back to the podcast to talk about the best available evidence for acetylsalicylic acid and its potential impact on reducing the…
BS Medicine Episode #554: Stress Urinary Incontinence: Pelvic floor exercises or pessary?
In episode 554, James and Mike go over a topic we have never covered in 553 previous podcasts. We invited Samantha Moe back to the podcast to talk about how…
BS Medicine Episode #553: How to Slow the Flow – Tranexamic acid for heavy menstrual bleeding
In episode 553, James and Mike get Jen Potter back to talk about the last option we have for heavy menstrual bleeding – tranexamic acid. We talk about how it…
November 12, 2021
Presenter(s):
Dr. Michael Allan James McCormack BSc (Pharm) Pharm D
Please provide any additional comments (optional).